Pursuing the secrets of a stealthy parasite
By unraveling the genetic pathways that help Toxoplasma gondii persist in human cells, Sebastian Lourido hopes to find new ways to treat toxoplasmosis.
By unraveling the genetic pathways that help Toxoplasma gondii persist in human cells, Sebastian Lourido hopes to find new ways to treat toxoplasmosis.
Genomics and lab studies reveal numerous findings, including a key role for Reelin amid neuronal vulnerability, and for choline and antioxidants in sustaining cognition.
Custom plates display expressions of scholarship, creativity, and MIT pride among Institute affiliates.
PhD student Xinyi Zhang is developing computational tools for analyzing cells in the age of multimodal data.
A new gene-silencing tool shows promise as a future therapy against prion diseases and paves the way for new approaches to treating disease.
Known for her rigorous approach to science and her influential research, Pardue paved the way for women in science at MIT and beyond.
With their “T-REX” method, DNA embedded in the polymer could be used for long-term storage of genomes or digital data such as photos and music.
By capturing short-lived RNA molecules, scientists can map relationships between genes and the regulatory elements that control them.
Senior Hanjun Lee planned to pursue chemistry at MIT. A course in genetics changed that.
Alnylam Pharmaceuticals, founded by MIT professors and former postdocs, has turned the promise of RNAi research into a new class of powerful therapies.
Single-cell gene expression patterns in the brain, and evidence from follow-up experiments, reveal many shared cellular and molecular similarities that could be targeted for potential treatment.
Researchers also found that a variant of the protein is not as protective against the bacteria and increases susceptibility to the disease.
With the new technique, MIT researchers hope to identify mutations that could be targeted with new cancer therapies.
A new study finds precancerous colon cells turn on a gene called SOX17, which helps them evade detection and develop into more advanced tumors.
MIT researchers can now track a cell’s RNA expression to investigate long-term processes like cancer progression or embryonic development.